Inquiry Into Practice of Sterilising Disabled Women
By Tom Nightingale,
ABC News (Australia)
| 11. 01. 2012
A Senate committee is looking into the controversial practice of sterilising disabled people, something many Australians are shocked to find is legal.
The UN is pushing for the practice to be banned and the Federal Government says it is looking at possible changes to laws.
The situation faced by the parents of disabled women is not black and white.
In one submission to the Senate inquiry, a mother explained the decision to stop her intellectually disabled daughter becoming pregnant.
"Her own life is not stable enough to support another life," the submission said.
"The reality is if this person had a child, that child would be dead within a week. Human services would have to be involved."
The woman's daughter is 27 and had a contraceptive device implanted four years ago to manage her periods.
The mother says she would not make the decision for anyone else, but with much thought and agonising she says her daughter should never have a child.
The anonymous submission says it is the right decision, given the disabled woman now has a boyfriend.
"Why...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...